JP Morgan Chase
MGNX icon

JP Morgan Chase’s MacroGenics MGNX Stock Holding History

JP Morgan Chase’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65.6K Buy
23,775
+18,022
+313% +$38.4K ﹤0.01% 6061
2025
Q4 		$9.26K Sell
5,753
-749,492
-99% -$1.18M ﹤0.01% 6686
2025
Q3 		$1.27M Buy
755,245
+295,108
+64% +$478K ﹤0.01% 4416
2025
Q2 		$557K Sell
460,137
-284,925
-38% -$413K ﹤0.01% 4721
2025
Q1 		$946K Buy
745,062
+198,255
+36% +$518K ﹤0.01% 4392
2024
Q4 		$1.78M Buy
546,807
+221,905
+68% +$799K ﹤0.01% 4240
2024
Q3 		$1.07M Sell
324,902
-155,359
-32% -$605K ﹤0.01% 4428
2024
Q2 		$2.04M Sell
480,261
-548,788
-53% -$5.34M ﹤0.01% 3772
2024
Q1 		$15.1M Sell
1,029,049
-105,695
-9% -$1.6M ﹤0.01% 2126
2023
Q4 		$10.9M Buy
1,134,744
+84,174
+8% +$582K ﹤0.01% 2377
2023
Q3 		$4.9M Sell
1,050,570
-199,422
-16% -$993K ﹤0.01% 2862
2023
Q2 		$6.69M Buy
1,249,992
+1,047,650
+518% +$6.46M ﹤0.01% 2645
2023
Q1 		$1.45M Sell
202,342
-33,755
-14% -$203K ﹤0.01% 3774
2022
Q4 		$1.58M Sell
236,097
-93,359
-28% -$512K ﹤0.01% 3738
2022
Q3 		$1.14M Sell
329,456
-69,598
-17% -$266K ﹤0.01% 3902
2022
Q2 		$1.18M Buy
399,054
+115,294
+41% +$606K ﹤0.01% 3957
2022
Q1 		$2.5M Buy
283,760
+187,724
+195% +$2.07M ﹤0.01% 3582
2021
Q4 		$1.54M Sell
96,036
-4,691
-5% -$88.3K ﹤0.01% 4043
2021
Q3 		$2.11M Sell
100,727
-7,573
-7% -$182K ﹤0.01% 3754
2021
Q2 		$2.91M Buy
108,300
+75,112
+226% +$2.2M ﹤0.01% 3511
2021
Q1 		$1.06M Sell
33,188
-77,495
-70% -$1.88M ﹤0.01% 4183
2020
Q4 		$2.53M Buy
110,683
+91,002
+462% +$2.1M ﹤0.01% 3312
2020
Q3 		$496K Buy
19,681
+3,558
+22% +$97.1K ﹤0.01% 3993
2020
Q2 		$450K Buy
16,123
+482
+3% +$8.37K ﹤0.01% 3898
2020
Q1 		$91K Buy
15,641
+15
+0.1% +$136 ﹤0.01% 4546
2019
Q4 		$170K Hold
15,626
– – ﹤0.01% 4734
2019
Q3 		$199K Sell
15,626
-11,260
-42% -$162K ﹤0.01% 4637
2019
Q2 		$448K Buy
26,886
+17,322
+181% +$298K ﹤0.01% 4290
2019
Q1 		$172K Sell
9,564
-21,039
-69% -$364K ﹤0.01% 4691
2018
Q4 		$388K Buy
30,603
+14,292
+88% +$240K ﹤0.01% 4259
2018
Q3 		$350K Sell
16,311
-3,275
-17% -$69.8K ﹤0.01% 4450
2018
Q2 		$405K Sell
19,586
-12,676
-39% -$286K ﹤0.01% 4268
2018
Q1 		$812K Buy
32,262
+6,178
+24% +$150K ﹤0.01% 3791
2017
Q4 		$496K Buy
26,084
+6,609
+34% +$123K ﹤0.01% 4063
2017
Q3 		$359K Sell
19,475
-800
-4% -$13.9K ﹤0.01% 3931
2017
Q2 		$355K Sell
20,275
-66,975
-77% -$1.28M ﹤0.01% 3846
2017
Q1 		$1.62M Sell
87,250
-11,350
-12% -$219K ﹤0.01% 3163
2016
Q4 		$2.02M Sell
98,600
-6,627
-6% -$167K ﹤0.01% 3067
2016
Q3 		$3.15M Sell
105,227
-113,664
-52% -$3.38M ﹤0.01% 2530
2016
Q2 		$5.91M Buy
218,891
+55,025
+34% +$1.24M ﹤0.01% 2178
2016
Q1 		$3.07M Sell
163,866
-84
-0.1% -$1.6K ﹤0.01% 2479
2015
Q4 		$5.08M Sell
163,950
-20,275
-11% -$616K ﹤0.01% 2222
2015
Q3 		$3.95M Sell
184,225
-8,825
-5% -$277K ﹤0.01% 2368
2015
Q2 		$7.33M Sell
193,050
-83,142
-30% -$2.73M ﹤0.01% 2143
2015
Q1 		$8.66M Buy
276,192
+89,221
+48% +$3.02M ﹤0.01% 1994
2014
Q4 		$6.56M Buy
186,971
+796
+0.4% +$19.8K ﹤0.01% 2228
2014
Q3 		$3.89M Sell
186,175
-1,275
-0.7% -$26.4K ﹤0.01% 2525
2014
Q2 		$4.07M Sell
187,450
-54,100
-22% -$1.14M ﹤0.01% 2184
2014
Q1 		$6.72M Buy
241,550
+121,126
+101% +$4.28M ﹤0.01% 1923
2013
Q4 		$3.3M Buy
+120,424
New +$3.15M ﹤0.01% 2429

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase's MGNX Position: Q1 2026 in Review

JP Morgan Chase increased its MacroGenics (MGNX) stake by 313% in Q1 2026, buying an estimated $38.4K and bringing the position to 23,775 shares worth $65.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6061.

JP Morgan Chase first reported a position in MGNX in Q4 2013 and has held it in 50 quarters since. The position peaked at $15.1M in Q1 2024. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • JP Morgan Chase held 23,775 shares of MacroGenics worth $65.6K as of Q1 2026.
  • JP Morgan Chase bought 18,022 MacroGenics shares in Q1 2026, an estimated $38.4K.
  • MacroGenics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6061 holding.
  • JP Morgan Chase first reported a position in MacroGenics in Q4 2013 and has held it in 50 quarters since.
  • JP Morgan Chase's MacroGenics position peaked at $15.1M in Q1 2024.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.